Clinical Trial Update: 68Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial investigating 68Ga-FAPI-46 PET/CT for assessing small bowel fibrostenosis in Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• 68Ga-FAPI-46 (Gallium-68-labeled FAPI-46)

Snippet

Sponsor: Mayo Clinic | Conditions: Crohn's Disease, Intestinal Fibrosis | EARLY_Phase 1 | Status: RECRUITING